Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Flushing, Oropharyngeal discomfort, Pruritus, Skin warm
Clinical narrative: BLOOD PRESSURE DIFFERENCE; MIGRAINE; ANAPHYLACTIC SHOCK; ANAPHYLACTIC REACTION TO DUST/POLLEN; PEANUT BUTTER/PINEAPPLE ALLERGY; HEALTH ISSUES; This spontaneous report received from a patient concerned a 48 year old female of unspecified race. The patient's height, and weight were not reported. The patient had no allergies prior to vaccination and was not allergic to malanga, peanut butter, pineapples, dust and pollen. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 22-JUN-2021) dose was not reported, 1 total administered to left arm on 08-APR-2021 for prophylactic vaccination.   The patient reported that within 30 minutes of vaccination, she experienced anaphylactic shock with symptoms of rash all over body, itchiness, a lot of cough and felt like she could not breath. The patient was taken to hospital from the vaccination site where she stayed for 8 hours before discharge. In the hospital, she received epinephrine, cimetidine, Pepcid, iohexol, potassium chloride and sodium chloride. In APR-2021 (Since vaccination), the patient became allergic to malanga, peanut butter, pineapples, dust and pollen. Patient developed second anaphylactic reaction on 20-APR-2021, when she was at work in the pharmacy and reported exposure to dust. She had the same problems with cough, shortness of breath and rash and was taken to same hospital, and was treated with epinephrine and prednisone. In MAY-2021, she also developed migraine for six months and had so much health issues since the vaccine. The patient reported that currently (NOV-2021) her blood pressure was at 140/90 which was not at this number before (blood pressure difference). The patient developed third anaphylactic reaction on 25-APR-2021, she had to go to emergency room and she thought it might be due to the dust again. The fourth anaphylactic reaction was on 29-APR-2021, where she had the reaction to pollen and the dust. It was reported that she had to change her job as a pharmacy technician to avoid exposure to dust in the pharmacy. She also reported that all the four times when she had the anaphylactic reaction, she had not stayed in hospital overnight but was discharged the same day. The patient was on montelukast and carries an Epipen with her. Currently the patient has a primary care provider, an allergist, and a cardiologist. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from peanut butter/pineapple allergy, migraine, blood pressure difference, health issues, and anaphylactic reaction to dust/pollen, and the outcome of anaphylactic shock was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211139657-covid-19 vaccine ad26.cov2.s-anaphylactic shock. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event(s). 20211139657-covid-19 vaccine ad26.cov2.s-anaphylactic reaction to dust/pollen. This event(s) is labeled per RSI and is therefore considered potentially related.